2022 Annual Meeting | N2 - Neuroscience in the Clinic: Applications of Artificial Intelligence and Machine Learning Tools in Neurology

Date Sunday 04/03/22

Time 03:30 PM - 05:30 PM PDT Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program will be available in the meeting's On Demand product.

Event Type Neuroscience in the Clinic Session

Director(s) Antonio M. Omuro, MD, FAAN, Sunil Sheth, MD

Topic(s) Neuro-oncology

Learning Objectives In this program, presenters will discuss recent applications of artificial intelligence (AI) within the field of neurology and highlight recent successes as well as existing challenges in AI applications for clinical practice. AI has shown promise by enabling rapid processing of an increasing amount of complex data, including cross-sectional imaging, histology, electrophysiology, and genomic data, which can aid with disease diagnosis, classification, risk stratification, prognosis, and treatment response. In this program, clinicians will review potential applications of these tools in a variety of specialties such as Stroke, Neuro-Oncology, Epilepsy, Multiple Sclerosis, Neuro-Imaging and others. Machine learning scientists will review the underlying principles and discuss the latest technological advances in the field, and provide tools to help neurologists understand the literature and embrace novel technologies. Select abstracts submitted to the AAN Annual meeting will then be discussed in depth, and questions from the audience will be addressed by the panel.

CME Available 2.00 CME credits

Core Competencies Patient Care & Procedural Skills, Medical Knowledge

Program Level Introductory

Recommended Audience Fellow, Resident, General Neurologist, Specialist Neurologist, Non-neurologist, Advanced Practice Provider, Neurohospitalist, Medical Student

Teaching Styles Case-based, Didactic

Program Materials Program Evaluations

Event Timeline
03:30 PM - 03:40 PM PDT	Speaker	How Can AI Help in Clinic? Antonio M. Omuro, MD, FAAN
03:30 PM - 03:30 PM PDT	Speaker	walk in slides Antonio M. Omuro, MD, FAAN
03:40 PM - 04:20 PM PDT	Speaker	The State of Machine Learning Technologies in Neurology Sunil Sheth, MD
04:20 PM - 04:30 PM PDT	Abstract	001 - A Machine Learning Approach to Automate Ischemic Stroke Subtyping Ashby Turner, MD
04:30 PM - 04:40 PM PDT	Abstract	002 - Optimized Computational Model in Predicting Multiple Sclerosis Clinical Outcomes Yujin Kim, BS
04:40 PM - 04:50 PM PDT	Abstract	003 - Development of a workflow efficient PACS based automated brain tumor segmentation and radiomic feature extraction for clinical implementation Mariam Aboian, MD, PhD
04:50 PM - 05:00 PM PDT	Abstract	004 - Seizure forecasting and detection with wearable devices and subcutaneous EEG - A Practical Seizure Gauge Benjamin H. Brinkmann, PhD
05:00 PM - 05:20 PM PDT	Speaker	Abstract Discussion Sanjay Aneja, MD
05:20 PM - 05:30 PM PDT	Q&A	Q&A and Panel discussion

Faculty Disclosures
Bibiana Bielekova, MD, FAAN	Dr. Bielekova has received research support from National Institutes of Allergy and Infectious Diseases. Dr. Bielekova has received intellectual property interests from a discovery or technology relating to health care. Dr. Bielekova has received publishing royalties from a publication relating to health care.
Mark Richardson, MD, MRCP	The institution of Dr. Richardson has received research support from Medical Research Council UK. The institution of Dr. Richardson has received research support from Epilepsy Research UK. The institution of Dr. Richardson has received research support from GW Pharma. The institution of Dr. Richardson has received research support from European Commission. The institution of Dr. Richardson has received research support from Autifony Therapeutics . The institution of Dr. Richardson has received research support from Epilepsy Foundation of America . Dr. Richardson has received intellectual property interests from a discovery or technology relating to health care.
Gregory A. Worrell, MD	Dr. Worrell has received stock or an ownership interest from NeuroOne Inc.. Dr. Worrell has received stock or an ownership interest from Cadence Neuroscience Inc. The institution of Dr. Worrell has received research support from NIH. The institution of Dr. Worrell has received research support from Medtronic Inc.. The institution of Dr. Worrell has received research support from Neuropace Inc,. The institution of Dr. Worrell has received research support from Epilepsy Foundation of America. Dr. Worrell has received intellectual property interests from a discovery or technology relating to health care. Dr. Worrell has received intellectual property interests from a discovery or technology relating to health care.
Antonio M. Omuro, MD, FAAN	Dr. Omuro has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ono Therapeutics. Dr. Omuro has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Telix. Dr. Omuro has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Curevac. The institution of Dr. Omuro has received research support from NIH. The institution of Dr. Omuro has received research support from Arcus Biosciences. The institution of Dr. Omuro has received research support from Denovo Biopharma. The institution of Dr. Omuro has received research support from Ono Pharmaceutical. The institution of Dr. Omuro has received research support from Servier. The institution of Dr. Omuro has received research support from Nanopharmaceuticals. The institution of Dr. Omuro has received research support from Denovo.
	No disclosure on file
Christopher D. Anderson, MD, PhD, FAAN	The institution of Dr. Anderson has received research support from Bayer AG. The institution of Dr. Anderson has received research support from American Heart Association. The institution of Dr. Anderson has received research support from National Institutes of Health. An immediate family member of Dr. Anderson has received publishing royalties from a publication relating to health care.
Sunil Sheth, MD	Dr. Sheth has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Penumbra. Dr. Sheth has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cerenovus. Dr. Sheth has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Imperative Care.
Andreas Schulze-Bonhage	Andreas Schulze-Bonhage has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BIAL, GW. Andreas Schulze-Bonhage has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for BIAL, GW, EISAI, UCB.
Benjamin H. Brinkmann, PhD	Dr. Brinkmann has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Eisai. Dr. Brinkmann has stock in Cadence Neuroscience. The institution of Dr. Brinkmann has received research support from Epilepsy Foundation of America. The institution of Dr. Brinkmann has received research support from National Institutes of Health. The institution of Dr. Brinkmann has received research support from National Institutes of Health. The institution of Dr. Brinkmann has received research support from UNEEG A/S. The institution of Dr. Brinkmann has received research support from Seer Medical Pty. The institution of Dr. Brinkmann has received research support from Neurelis Inc. Dr. Brinkmann has received intellectual property interests from a discovery or technology relating to health care.
Mihael V. Varosanec, MD	Dr. Varosanec has received research support from NIH.
Ashby Turner, MD	Dr. Turner has nothing to disclose.
Peter Kosa, PhD	Dr. Kosa has nothing to disclose.
Nicholas M. Gregg, MD	No disclosure on file
Gabriel I. Cassinelli Petersen	Mr. Cassinelli Petersen has nothing to disclose.
Yujin Kim, BS	Ms. Kim has nothing to disclose.
Mariam Aboian, MD, PhD	Dr. Aboian has a non-compensated relationship as a Principal Investigator with Visage Imaging that is relevant to AAN interests or activities.
Ryan C. Bahar	Mr. Bahar has nothing to disclose.
Sara Merkaj	Mrs. Merkaj has nothing to disclose.
Sanjay Aneja, MD	An immediate family member of Dr. Aneja has received personal compensation for serving as an employee of Prophet Consultancy. An immediate family member of Dr. Aneja has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Prophet Consultancy. Dr. Aneja has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for JCO Cancer Clinical Informatics. An immediate family member of Dr. Aneja has stock in Prophet Consultancy. The institution of Dr. Aneja has received research support from National Cancer Institute. The institution of Dr. Aneja has received research support from National Science Foundation. The institution of Dr. Aneja has received research support from American Society of Clinical Oncology. The institution of Dr. Aneja has received research support from Reflexion Medical. The institution of Dr. Aneja has received research support from Agency for Health Research and Quality. The institution of Dr. Aneja has received research support from Patterson Family Trust. Dr. Aneja has received personal compensation in the range of $100,000-$499,999 for serving as a Assistant Professor with Yale University.
Dean Freestone	No disclosure on file
Ajay Malhotra	Ajay Malhotra has nothing to disclose.
Sam Payabvash	Sam Payabvash has nothing to disclose.
Caitlin Grzeskowiak	No disclosure on file
Amit Mahajan	No disclosure on file

��ɫ��

��ɫ��